Abstract
A 70-y-old woman was referred for a dual-isotope subtraction scintigraphy with 123I and 99mTc-sestamibi in combination with SPECT/CT and ultrasound for the localization of parathyroid adenoma. Aside from a possible parathyroid adenoma, the SPECT/CT scan showed increased and focal 99mTc-sestamibi uptake in the right upper lung. A biopsy revealed a primary non–small cell lung adenocarcinoma. Nonparathyroid findings during parathyroid scintigraphy are frequent and can lead to newly diagnosed malignant or premalignant lesions, providing an important opportunity to optimize treatment.
Footnotes
Published online May 9, 2025.
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user